Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relapse in Dementia-related Psychosis and Clinical Decisions.
Soto-Martin M, Foff EP, Devanand DP. Soto-Martin M, et al. Among authors: devanand dp. Alzheimer Dis Assoc Disord. 2022 Apr-Jun 01;36(2):180-184. doi: 10.1097/WAD.0000000000000480. Epub 2022 Feb 9. Alzheimer Dis Assoc Disord. 2022. PMID: 35137699 Free PMC article. Clinical Trial.
Trial of Pimavanserin in Dementia-Related Psychosis.
Tariot PN, Cummings JL, Soto-Martin ME, Ballard C, Erten-Lyons D, Sultzer DL, Devanand DP, Weintraub D, McEvoy B, Youakim JM, Stankovic S, Foff EP. Tariot PN, et al. Among authors: devanand dp. N Engl J Med. 2021 Jul 22;385(4):309-319. doi: 10.1056/NEJMoa2034634. N Engl J Med. 2021. PMID: 34289275 Clinical Trial.
Pimavanserin and dementia-related psychosis.
Tariot PN, Ballard C, Devanand DP, Cummings JL, Sultzer DL. Tariot PN, et al. Among authors: devanand dp. Lancet Neurol. 2022 Feb;21(2):114-115. doi: 10.1016/S1474-4422(21)00466-X. Lancet Neurol. 2022. PMID: 35065031 No abstract available.
Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment: Metformin in Alzheimer Dementia Prevention (MAP).
Luchsinger JA, Devanand D, Goldberg TE, Cammack S, Hernández-Santiago G, Oishi K, Jagust W, Baker S, Landau S, Yenokyan G, Betz J, Mayers S, Eyzaguirre LM, Hanley D; MAP Study Group. Luchsinger JA, et al. Alzheimer Dis Assoc Disord. 2025 Apr-Jun 01;39(2):123-133. doi: 10.1097/WAD.0000000000000677. Epub 2025 May 28. Alzheimer Dis Assoc Disord. 2025. PMID: 40434891
294 results